Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion
Roche Holding AG Ordinary Shares new RHHVF
News
Roche Halts Development of Obesity Drug Candidate
Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial — Update
European Pharma Leaders Push for National Reforms to Boost Investment
Roche's Susvimo Gets European Union Approval
Hutchmed Enters Licensing Agreement With GSK for Cancer Drug
Roche, Simcere Pharma Strike Drug Licensing Deal
FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly
Hanmi Pharmaceutical Shares Jump After Signing $2.31 Billion Licensing Deal With Genentech
Roche's U.S. Subsidiary Genentech to Invest $750 Million in Manufacturing Expansion
'I didn't know what else to do': Patients take their health-insurance battles to Facebook and LinkedIn
Roche Launches Two Cyclospora Testing Options
Roche Backs Full-Year View as First-Half Sales Rise
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
FDA Approves First Generic Single-Dose Flu Treatment
Roche Licenses Nurix Therapeutics Blood-Cancer Drug for Up to $2.3 Billion — Update
Nurix Therapeutics Shares Surge Premarket on Roche Deal
Roche Enters $2.3 Billion Blood-Cancer Drug Deal With Nurix Therapeutics
Immunic Names Erik Lundgren Chief Executive
United States